UNSPSC 51303203: Lidimycin or lydimycin

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U1E84J0228. European Medicines Agency schedules Lidimycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08506MIG. Lidimycin generally arises in the molecular formula C10H14N2O3S.

The term LIDIMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, no. 10 1969, list 9.) LIDIMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Lidimycin or lydimycin bears US NLM identifiers UMLS ID C2983836 and NCI Concept Code C90684. SMILES: C1C2C(C(S1)CC/C=C/C(=O)O)NC(=O)N2.

UNSPSC 51303203 Lidimycin or lydimycin, a Commodity code, sees limited recent activity in state and local procurement. The City of Tampa's Fire Rescue Department posted an Invitation to Bid (ITB 25-P-00157) in April 2026 for Medical Aid Supplies, a 32-item procurement covering antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets with annual quantities ranging from 1 to 2,700 units per line item. The solicitation carries a $100,000 department budget and targets an initial one-year award with potential two-year renewals. All medications must maintain a minimum nine-month expiration date from acceptance. The City reserves discretion to award by aggregate total or individual line items and includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount capped at $10,000 for SLBEs and $20,000 for U-WMBEs.

The code shows minimal recent activity concentrated in Florida. The Tampa Fire Rescue Department's ITB, with a response deadline of April 9, 2025 (posted April 24, 2026), represents the sole recent state or local opportunity documented under this code. The mismatch between the code's pharmaceutical specificity — lidimycin or lydimycin — and the broad medical aid supply procurement suggests that state and local procurement offices may tag first-aid and emergency medical supply solicitations to this code inconsistently. Few other issuing bodies appear to use this code for regular purchasing, and no geographic concentration beyond Florida emerges from current activity. The lack of additional recent opportunities indicates low velocity in the state and local marketplace under this specific commodity designation.